Solventum Corporation
$7.1M 24,481 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Insulet Corporation
Insulet Corporation reported $7,202,281.81 across General Payments, Research, and Ownership to 17,948 physicians and teaching hospitals across 18,137 transactions.
- $7.2M Top quartile payer
- All-tracks total
- 18,137 Top 10% volume
- Transactions
- 17,948 Top 10% reach
- Recipients
- +$1.8M
- General Payments vs PY2023
Insulet Corporation reported $7,202,281.81 across all CMS Open Payments tracks (General + Research + Ownership) to 17,948 physicians and teaching hospitals in Program Year 2024 - ranking #218 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $3,862,461.10, averaging $401.29 per recipient.
How Insulet Corporation's $7.2M all-tracks total breaks down
Insulet Corporation's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
B
89/100
Total payments
C
77/100
Transaction volume
A
100/100
Physician reach
A
100/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer insulet-corporation Insulet Corporation
$7.2M · #218/1,925 · 0.1% industry · PY2024
- TOT $7.2M
- RANK #218
- SHARE 0.1%
- TXN 18,137
- RCP 17,948
- CAT 6
- GEN $3.9M
- ΔGEN +$1.8M
- TOP1 5.4%
- PY 2024
Volume peers
Nearest volume peer: Solventum Corporation ($7.1M)
Insulet Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Insulet Corporation's CMS-reported General Payments increased by $1.8M (+86.5%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: INSULET CORPORATIONPY2023: INSULET CORPORATIONPY2024: Insulet Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $2,070,874.16
- PY2024
- $3,862,461.10
What the Data Shows for Insulet Corporation
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Insulet Corporation, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 6 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $3.0M across 1,862 transactions, 76.6% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 6 types of general payments, Insulet Corporation's largest category was "Compensation for Services Other Than Consulting" at $3.0M - 76.6% of General Payments.
Insulet Corporation reports 6 general-payment categories - the top three are Compensation for Services Other Than Consulting (76.6%), Food and Beverage (10.5%), and Compensation for Faculty or Speaker (Medical Education) (10.2%). The remaining 3 categories make up 2.7% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Insulet Corporation divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $3.0M | 1,862 | 76.6% |
| Food and Beverage | $406.1K | 15,070 | 10.5% |
| Compensation for Faculty or Speaker (Medical Education) | $393.2K | 270 | 10.2% |
| Travel and Lodging | $76.9K | 726 | 2.0% |
| Space Rental or Facility Fees | $21.7K | 19 | 0.6% |
| Grant | $6.0K | 1 | 0.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $676,469.96 (17.5%) of $3,862,461.10 in this company's General Payments records across 5,953 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Insulet Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Cleveland Clinic Hospital
$209,975.00 across 61 reported transactions
- 2
Anita Narayan Swamy
$131,344.96 across 198 reported transactions
- 3
Childrens Hospital Of The Kings Da
$116,475.00 across 24 reported transactions
- 4
Parkview Hospital
$110,100.00 across 29 reported transactions
- 5
Deaconess Medical Center
$108,575.00 across 30 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Insulet Corporation ranks #218 of 1,925 by total payments (top 11% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,638 of 1,838 by HHI (bottom 11% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Scpharmaceuticals Inc. : $980.4K total payments, HHI 141
- Mannkind Corporation : $423.2K total payments, HHI 141
- Hill Dermaceuticals, Inc. : $15.7K total payments, HHI 140
- Axogen : $1.8M total payments, HHI 139
- Johnson and Johnson International : $11.1K total payments, HHI 138
- Alon Medical Technology : $48.8K total payments, HHI 138
- Insulet Corporation (this company) : $3.9M total payments, HHI 137
- KVK-Tech, Inc. : $4.6K total payments, HHI 135
- Genmab U.S., Inc. : $2.1M total payments, HHI 135
- Olympus America Inc. : $2.8M total payments, HHI 133
- Breas Medical, Inc. : $4.0K total payments, HHI 132
- Ethicon Inc. : $2.2M total payments, HHI 132
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Insulet Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Insulet Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Insulet Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
Neurology Practice Consortium Gpo, LLC
$7.0M 0 recipients
Compare payment profiles
Skye Orthobiologics LLC
$7.4M 38 recipients
Compare payment profiles
Woven Orthopedic Technologies, LLC
$7.0M 11 recipients
Compare payment profiles
Dompe Farmaceutici S.p.A.
$6.9M 7 recipients
Compare payment profiles
Astellas Pharma Inc
$6.9M 81 recipients
Compare payment profiles
Put this to use
Insulet Corporation ranks #218 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See where Insulet Corporation sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Insulet Corporation. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.